Reliq Health Technologies Stock EBITDA
| RHT Stock | CAD 0.22 0.00 0.00% |
Reliq Health Technologies fundamentals help investors to digest information that contributes to Reliq Health's financial success or failures. It also enables traders to predict the movement of Reliq Stock. The fundamental analysis module provides a way to measure Reliq Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Reliq Health stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -7.3 M | -6.9 M |
Reliq | EBITDA |
Reliq Health Technologies Company EBITDA Analysis
Reliq Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Reliq Health EBITDA | (1.21 M) |
Most of Reliq Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Reliq Health Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Reliq EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Reliq Health is extremely important. It helps to project a fair market value of Reliq Stock properly, considering its historical fundamentals such as EBITDA. Since Reliq Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Reliq Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Reliq Health's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Reliq Ebitda
According to the company disclosure, Reliq Health Technologies reported earnings before interest,tax, depreciation and amortization of (1.21 Million). This is 100.13% lower than that of the Health Care Technology sector and 101.0% lower than that of the Health Care industry. The ebitda for all Canada stocks is 100.03% higher than that of the company.
Reliq EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Reliq Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Reliq Health could also be used in its relative valuation, which is a method of valuing Reliq Health by comparing valuation metrics of similar companies.Reliq Health is currently under evaluation in ebitda category among its peers.
Reliq Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Reliq Health from analyzing Reliq Health's financial statements. These drivers represent accounts that assess Reliq Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Reliq Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 30.8M | 36.5M | 76.6M | 87.0M | 2.4M | 2.3M | |
| Enterprise Value | 30.4M | 37.0M | 76.8M | 87.1M | 2.4M | 2.3M |
Reliq Fundamentals
| Return On Equity | -0.0449 | ||||
| Return On Asset | -0.053 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 43.39 M | ||||
| Shares Outstanding | 196.76 M | ||||
| Shares Owned By Insiders | 1.76 % | ||||
| Shares Owned By Institutions | 2.81 % | ||||
| Number Of Shares Shorted | 504.11 K | ||||
| Price To Book | 5.12 X | ||||
| Price To Sales | 3.19 X | ||||
| Revenue | 14.62 M | ||||
| Gross Profit | 5.3 M | ||||
| EBITDA | (1.21 M) | ||||
| Net Income | (8.17 M) | ||||
| Cash And Equivalents | 1.92 M | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 305 K | ||||
| Current Ratio | 5.40 X | ||||
| Book Value Per Share | 0.07 X | ||||
| Cash Flow From Operations | (8.03 M) | ||||
| Short Ratio | 13.30 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 1.75 | ||||
| Beta | 1.54 | ||||
| Market Capitalization | 46.65 M | ||||
| Total Asset | 10.27 M | ||||
| Retained Earnings | (69.87 M) | ||||
| Working Capital | 3.26 M | ||||
| Net Asset | 10.27 M |
About Reliq Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Reliq Health Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reliq Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reliq Health Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Reliq Stock Analysis
When running Reliq Health's price analysis, check to measure Reliq Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reliq Health is operating at the current time. Most of Reliq Health's value examination focuses on studying past and present price action to predict the probability of Reliq Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reliq Health's price. Additionally, you may evaluate how the addition of Reliq Health to your portfolios can decrease your overall portfolio volatility.